Ethicon Endo-Surgery

Company background 

For more information, please contact: 

Angelika Elser 

Director Public Affairs and Communication 

Ethicon Endo-Surgery EMEA 

T: +49 40 5297 3306 

M: aelser@its.jnj.com 

Ethicon Endo-Surgery 

Ethicon Endo-Surgery is the global market leader for both minimally invasive and 

traditional mechanical devices. 

Formed in 1992 as a subsidiary of the internationally renowned Johnson & Johnson 

family of companies, Ethicon Endo-Surgery develops and markets a broad portfolio 

of advanced surgical instruments. 

The company focuses on procedure-enabling devices for diagnostics and treatment. 

It is an expert in fields including gynaecology, breast care, bariatrics, gastrointestinal 

health, and surgical oncology. 

Ethicon Endo-Surgery core markets include laparoscopic surgical instruments such 

as surgical cutting and stapling devices, access instruments such as trocars, and the 

use of advanced energy technologies in surgery. 

Ethicon Endo-Surgery’s mission is to transform patient care through innovation. It 

continually seeks new ways to ensure that developments in surgical instrumentation 

and expertise translate into patient benefits. 

This means that the company is able to develop innovative surgical products that 

contribute to patient recovery and wellbeing through earlier detection and treatment, 

efficient surgical procedures and faster recovery. 

Ethicon Endo-Surgery employs over 4000 people worldwide and its products are 

available in over 50 countries. Its global headquarters are in Cincinnati, USA, and its 

EMEA headquarters in Norderstedt (near Hamburg), Germany. 

A proud heritage 

Ethicon Endo-Surgery is descended from one of the world’s best-known expert 

manufacturers of health care products. Johnson & Johnson was founded by the 

Johnson Brothers in 1886 and has grown to include over 250 companies in 57 

countries. 

Employees of the Johnson & Johnson Family of Companies today work with partners 

in health care to touch the lives of over a billion people around the world every day. 

Ethicon Endo-Surgery (Europe) GmbH 

Hummelsbütteler Steindamm 71, 

22851 Norderstedt / Germany

Originally part of a J&J operating company called Ethicon, Ethicon Endo-Surgery 

was formed as a separate company in 1992 to develop endoscopic (minimally 

invasive) devices, in the early days of the market for ‘keyhole surgery’. 

Since then, Ethicon Endo-Surgery has expanded into energy-based instruments and 

medical diagnostics. Since 1995 Ethicon Endo-Surgery has been the market leader 

in surgical devices for minimally invasive and open surgery, as well as a major 

contributor to the continued growth of Johnson & Johnson itself. 

Innovation and quality 

Research and development (R&D) is a central part of Ethicon Endo-Surgery’s 

business. In 2006, Ethicon Endo-Surgery spent nearly $300million on R&D. The 

company launched 27 new products between 2004 and 2007. 

Products are produced in state-of-the-art manufacturing facilities in Albuquerque, 

New Mexico (USA) and Juarez, Mexico. Quality Systems are certified according to 

EN ISO 9001. 

All products are extensively tested before being brought to the market. Their 

performance is constantly reviewed. 

Ethicon Endo-Surgery invests in producing the evidence to prove the value of its 

products. Ethicon Endo-Surgery products have been approved by national HTA 

bodies across Europe, including NICE in England and HAS in France, as testimony 

to their clinical and economic benefits. 

Priceless education 

Ethicon Endo-Surgery is committed to quality: through product development and 

professional education. 

The European Surgical Institute (ESI), in Norderstedt near Hamburg, is a world class 

Ethicon Endo-Surgery medical education and surgical training centre. ESI is the most 

modern training centre for continuous medical education in the Europe, Middle East 

and Africa (EMEA). It has educated over 110,000 healthcare specialists since its 

foundation. 

State-of-the-art Endo-Surgical Institutes are also located in the US and Japan 

(Cincinnati and Sukagawa). 

In addition, Ethicon Endo-Surgery works with local Centres of Excellence to provide 

easy access to education for thousands of national surgeons every year. 





T: +49 40 5297 3306 





A serious responsibility 

Ethicon Endo-Surgery believes it has a broad human responsibility: to every patient 

who benefits from Ethicon Endo-Surgery products and procedures, to the doctors 

and nurses who depend on its products, and to its own employees. 

Ethicon Endo-Surgery also maintains a commitment to help the broader community 

beyond the operating table. 

In 1943 Johnson & Johnson wrote ‘Our Credo’, setting out the guiding ethical 

principles for J&J companies. The credo states that the companies’ first 

responsibility is to all those “who use our products and services,” from doctors and 

parents to patients. It then stresses the responsibility to employees, communities 

and stockholders. 

In 2008 William C. Weldon, Chairman and Chief Executive Officer, Johnson & 

Johnson, based a new company Statement of Caring on Our Credo: 

“Caring for the world . . . one person at a time inspires and unites the people of 

Johnson & Johnson. We embrace research and science - bringing innovative ideas, 

products and services to advance the health and well-being of people. Employees of 

the Johnson & Johnson Family of Companies work with partners in health care to 

touch the lives of over a billion people every day, throughout the world.” 

The company supports Johnson & Johnson’s philanthropic efforts and communitybased 

partnerships. These focus on making long-term differences in human health 

by taking on some of the world’s major health challenges. Efforts are built around 

three key areas; saving and improving the lives of women and children; building the 

skills of local community health workers; and tackling the spread of diseases and 

related stigma and disability in poor communities. 

Ethicon Endo-Surgery and Johnson & Johnson also remain committed to 

environmental protection. In 1999 Johnson & Johnson said it would reduce its 

companies’ CO2 emissions from 1990 levels by 7% by 2010. By the end of 2006, 

Johnson & Johnson companies had cut CO2 emissions by 16.8%. This outstanding 

result came about through a combination of increased energy efficiency, clean, 

renewable power and offsets, and on-site renewable energy and co-generation. 





T: +49 40 5297 3306

Ethicon Endo-Surgery

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?